Search by Drug Name or NDC
NDC 00404-9966-02 Verapamil Hydrochloride 2.5 mg/mL Details
Verapamil Hydrochloride 2.5 mg/mL
Verapamil Hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Henry Schein, Inc.. The primary component is VERAPAMIL HYDROCHLORIDE.
Product Information
| NDC | 00404-9966 |
|---|---|
| Product ID | 0404-9966_5ebf59d0-1088-4655-a153-c2bede8ee6ee |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Verapamil Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Verapamil Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Labeler Name | Henry Schein, Inc. |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211015 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00404-9966-02 (00404996602)
| NDC Package Code | 0404-9966-02 |
|---|---|
| Billing NDC | 00404996602 |
| Package | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9966-02) / 2 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-01-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |